These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32869658)

  • 1. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
    Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expectant vs medical management for retained products of conception after medical termination of pregnancy: a randomized controlled study.
    Tzur Y; Berkovitz-Shperling R; Goitein Inbar T; Bar-On S; Gil Y; Levin I; Cohen A
    Am J Obstet Gynecol; 2022 Oct; 227(4):599.e1-599.e9. PubMed ID: 35752301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Lemmers M; Verschoor MAC; Overwater K; Bossuyt PM; Hendriks D; Hemelaar M; Schutte JM; Adriaanse AH; Ankum WM; Huirne JAF; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():78-82. PubMed ID: 28199872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of retained products of conception after miscarriage or termination with gemeprost in the second trimester of pregnancy: a retrospective case-controlled study in Japanese population.
    Noguchi T; Shiro M; Nanjo S; Mizoguchi M; Ota N; Mabuchi Y; Yagi S; Minami S; Ino K
    J Obstet Gynaecol; 2022 Apr; 42(3):501-504. PubMed ID: 34162287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of introducing medical management on conservative and surgical management for early pregnancy miscarriage.
    Black KI; de Vries BS; Moses F; Pelosi M; Cong A; Ludlow J
    Aust N Z J Obstet Gynaecol; 2017 Feb; 57(1):93-98. PubMed ID: 28251638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study.
    Lemmers M; Verschoor MAC; Oude Rengerink K; Naaktgeboren C; Bossuyt PM; Huirne JAF; Janssen IAH; Radder C; Klinkert ER; Langenveld J; van der Voet L; Siemens FF; Bongers MY; van Hooff MH; van der Ploeg M; Sjors FPJ; Coppus SFPJ; Ankum WM; Mol BWJ;
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():83-89. PubMed ID: 28209537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of misoprostol for early pregnancy failure.
    Tang OS; Ho PC
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):581-6. PubMed ID: 17099326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for office aspiration curettage in cases of retained products of conception: A randomized controlled trial.
    Pomeranz M; Goren Gepstein N; Ovadia M; Klein Z; Daykan Y; Schonman R; Arbib N
    Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2076-2081. PubMed ID: 34467531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
    Hershko Klement A; Frederic M; Bentov Y; Chang P; Nayot D; Haas J; Casper RF
    Gynecol Endocrinol; 2018 Jul; 34(7):609-611. PubMed ID: 29345165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review.
    Hooker AB; Aydin H; Brölmann HA; Huirne JA
    Fertil Steril; 2016 Jan; 105(1):156-64.e1-2. PubMed ID: 26453977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage.
    Bagratee JS; Khullar V; Regan L; Moodley J; Kagoro H
    Hum Reprod; 2004 Feb; 19(2):266-71. PubMed ID: 14747165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive outcome after early pregnancy loss treated with misoprostol versus surgical aspiration.
    Mizrachi Y; Ben-Ezry E; Kleiner I; Friedman G; Kerner R; Bar J; Raziel A; Weissman A; Sagiv R
    Reprod Biomed Online; 2020 Oct; 41(4):707-713. PubMed ID: 32819838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive outcome after early miscarriage: comparing vaginal misoprostol treatment with expectant management in a planned secondary analysis of a randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):100-106. PubMed ID: 34523740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.